The Discounted Cash Flow (DCF) valuation of Vertex Pharmaceuticals Inc (VRTX) is 539.58 USD. With the latest stock price at 485.65 USD, the upside of Vertex Pharmaceuticals Inc based on DCF is 11.1%.
Based on the latest price of 485.65 USD and our DCF valuation, Vertex Pharmaceuticals Inc (VRTX) is a buy. buying Vertex stocks now will result in a potential gain of 11.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.1% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 349.36 - 1,438.71 | 539.58 |
| Upside | -28.1% - 196.2% | 11.1% |